ConductScience.org, home

Paper32101660

Escaping Pandora's Box - Another Novel Coronavirus.

Morens DM and 2 others. N Engl J Med, 2020. Cited by 146 papers, by iCite.

Cite this record

ConductScience Library. Escaping Pandora's Box - Another Novel Coronavirus. Papers, record 32101660. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32101660

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Escaping Pandora's Box - Another Novel Coronavirus.
PubMed
Journal
N Engl J Med
PubMed
Year
2020
PubMed
Publication types
Historical Article, Journal Article
PubMed
Citations, by iCite
146
iCite
Relative citation ratio, by iCite
6.32
iCite
Revised in PubMed
2022-12-07
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Morens DMDavid M
2Daszak PPeter
3Taubenberger JKJeffery K

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BetacoronavirusMajor topic
ChiropteraMajor topic
Coronavirus InfectionsMajor topic
PandemicsMajor topic
Pneumonia, ViralMajor topic
ZoonosesMajor topic
Animals
COVID-19
History, 19th Century
History, 20th Century
Humans
Influenza Pandemic, 1918-1919
Middle East Respiratory Syndrome Coronavirus
Severe acute respiratory syndrome-related coronavirus
SARS-CoV-2
Severe Acute Respiratory Syndrome
Virus Diseases

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
ZIAAI001271NIH

Source NIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04558125Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary EmbolismBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by114

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.

PMIDTitleJournalYearIn PapersSource
42361016Gendered male and high-income country authors dominate publication at a One Health research organization.PLoS One2026https://conductscience.org/library/papers/42361016PubMed
42053295Pseudovirus-mediated proximity labeling identifies candidate host cell membrane proteins involved in viral attachment.J Virol2026https://conductscience.org/library/papers/42053295PubMed
41398910Development and evaluation of a novel nebulized dihydromyricetin formulation: enhanced pulmonary delivery and pharmacokinetic properties.Respir Res2025https://conductscience.org/library/papers/41398910PubMed
40741277Outcomes of SARS-CoV-2 infection in patients under treatment with pharmacological immunosuppression. A Swiss cohort study.Arch Med Sci2025https://conductscience.org/library/papers/40741277PubMed
40720505Early pandemic associations of latitude, sunshine duration, and vitamin D status with COVID-19 incidence and fatalities: A global analysis of 187 Countries.PLOS Glob Public Health2025https://conductscience.org/library/papers/40720505PubMed
39247005Did the Coronavirus Disease 2019 (COVID-19) Pandemic Cause a Delay in the Diagnosis of Breast Cancer Patients?Cureus2024https://conductscience.org/library/papers/39247005PubMed
38171875An Elderly Patient Developed Ulcerative Colitis after SARS-CoV-2 mRNA Vaccination: A Case Report and Review of the Literature.Intern Med2024https://conductscience.org/library/papers/38171875PubMed
37448935Revitalizing primary care is the key to people's health in the post-COVID era.J Family Med Prim Care2023https://conductscience.org/library/papers/37448935PubMed
37196023Monitoring and responding to emerging infectious diseases in a university setting: A case study using COVID-19.PLoS One2023https://conductscience.org/library/papers/37196023PubMed
37140873Impact of SARS-CoV-2 infection in patients with hereditary hemorrhagic telangiectasia: epidemiological and clinical data from the comprehensive Italian retrospective multicenter study.Intern Emerg Med2023https://conductscience.org/library/papers/37140873PubMed
36992209Epidemiology of the Acceptance of Anti COVID-19 Vaccine in Urban and Rural Settings in Cameroon.Vaccines (Basel)2023https://conductscience.org/library/papers/36992209PubMed
36936870Serum titer of neutralizing antibodies after COVID-19 vaccination in Japanese patients with inflammatory bowel disease.J Clin Biochem Nutr2023https://conductscience.org/library/papers/36936870PubMed
36817436Comprehensive analysis to identify the influences of SARS-CoV-2 infections to inflammatory bowel disease.Front Immunol2023https://conductscience.org/library/papers/36817436PubMed
36417106An older patient with active ulcerative colitis and coronavirus disease 2019 (COVID-19) pneumonia successfully treated with the combination of anti-TNFα therapy and azathioprine.Clin J Gastroenterol2023https://conductscience.org/library/papers/36417106PubMed
36378059Effectiveness of Liu-zi-jue exercise on coronavirus disease 2019 in the patients: a randomized controlled trial.J Tradit Chin Med2022https://conductscience.org/library/papers/36378059PubMed
36267993Trends of myopia development among primary and junior school students in the post-COVID-19 epidemic period.Front Public Health2022https://conductscience.org/library/papers/36267993PubMed
36215506Pandemic origins and a One Health approach to preparedness and prevention: Solutions based on SARS-CoV-2 and other RNA viruses.Proc Natl Acad Sci U S A2022https://conductscience.org/library/papers/36215506PubMed
36142955Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study.J Clin Med2022https://conductscience.org/library/papers/36142955PubMed
35960372The 'welcomed lockdown' hypothesis? Mental wellbeing and mobility restrictions.Eur J Health Econ2023https://conductscience.org/library/papers/35960372PubMed
35948797Multi-region machine learning-based novel ensemble approaches for predicting COVID-19 pandemic in Africa.Environ Sci Pollut Res Int2023https://conductscience.org/library/papers/35948797PubMed

See all 114 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32101660

GET https://conductscience.org/api/papers/v1/32101660/cited_by?page=2